His research is focussed upon liver cancer prevention and treatment, chronic liver disease pathogenesis, diabetes, protein and enzyme biochemistry and cell biology related to the proteases DPP4, DPP9 and fibroblast activation protein (FAP). He has authored over 163 publications attracting H index 46, i10 index 110 and > 7,600 citations. His research experience also includes small RNA viruses, transcriptomics, proteomics and cell biology. His research was important in the development of DPP4-targetted therapies for type 2 diabetes, which are now used to treat millions of patients. Inside Centenary Institute,he chairs the postgraduate research and equipment grants committees, is an Academic Leader for postgraduate research and a Commercialisation Committee member. Outside Centenary Institute, he is active in the International Proteolysis Society, the Gastroenterological Society of Australia, NHMRC, MRFF and Flanders Fund grant reviews, and editorial boards of journals including Cancers andScientific Reports.